Bio-Rad Laboratories
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BIO.B and other ETFs, options, and stocks.About BIO.B
Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Science and Clinical Diagnostics segments.
CEONorman D. Schwartz
CEONorman D. Schwartz
Employees7,700
Employees7,700
HeadquartersHercules, California
HeadquartersHercules, California
Founded1952
Founded1952
Employees7,700
Employees7,700
BIO.B Key Statistics
Market cap8.26B
Market cap8.26B
Price-Earnings ratio-12.57
Price-Earnings ratio-12.57
Dividend yield—
Dividend yield—
Average volume262.40
Average volume262.40
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$359.22
52 Week high$359.22
52 Week low$225.29
52 Week low$225.29
Stock Snapshot
Bio-Rad Laboratories(BIO.B) stock is priced at $305.40, giving the company a market capitalization of 8.26B. It carries a P/E multiple of -12.57.
On 2025-11-09, Bio-Rad Laboratories(BIO.B) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 262.4.
The stock's 52-week range extends from a low of $225.29 to a high of $359.22.
The stock's 52-week range extends from a low of $225.29 to a high of $359.22.
BIO.B News
Simply Wall St 7d
Is Bio-Rad Sending a New Signal With Expanded Buybacks and Diagnostic Partnerships?Bio-Rad Laboratories reported third-quarter 2025 earnings with sales rising to US$653 million and disclosed a net loss of US$341.9 million, while completing a s...
Analyst ratings
57%
of 7 ratingsBuy
42.9%
Hold
57.1%
Sell
0%
People also own
Based on the portfolios of people who own BIO.B. This list is generated using Robinhood data, and it’s not a recommendation.